There is currently no generic version of semaglutide on the market that has been approved by Health Canada, while branded semaglutide can cost more than $200 a month. Photo by CR/Getty Images/Postmedia files

Hims & Hers Health, Inc. has officially entered the Canadian market with its recent acquisition of Livewell, an online telehealth platform focused on weight loss .

The United States telehealth upstart said the move is expected to help accelerate its platform’s official launch in Canada next year.

Hims & Hers’ planned launch is timed to align with the first anticipated availability of generic semaglutide anywhere in the world. The drug, popularized by the brand Ozempic and used in the treatment of type 2 diabetes, has been widely prescribed as an anti-obesity medicatio

See Full Page